Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
This substance was identified for action under the Chemicals Management Plan (CMP).
|Substance Group||CAS RN||Common Name||DSL Name||Draft Screening Assessment||Proposed Conclusion on Section 64 criteria||Follow-up Activities|
|Short-chain alkanes||74-84-0||Ethane||Ethane||HTML||Does not meet||None planned at this time|
|75-28-5||Isobutane, in the absence of 1,3-butadiene||Propane, 2-methyl|
|106-97-8||Butane, in the absence of 1,3-butadiene||Butane|
|68513-65-5||Butane, branched and linear||Butane, branched and linear|
|December 2017||Anticipated release of the final screening assessment in Canada Gazette.|
|January 28, 2017||Publication and start of 60-day public comment period on the draft screening assessment. The related Notice was published in the Canada Gazette, Part I: Vol. 151, No. 4.|
The substance 1,3-butadiene was assessed by the Government of Canada in 2000 and was found to be harmful to human health and to the environment. It was added to the List of Toxic Substances in Schedule 1 of the Canadian Environmental Protection Act, 1999 (CEPA 1999), and is currently subject to ongoing risk management activities.
The substances isobutane containing 1,3-butadiene and butane containing 1,3-butadiene were assessed under the Challenge initiative under the Chemicals Management Plan in 2009. The screening assessment concluded that exposure to 1,3-butadiene from the uses of butane and isobutane should be considered in relation to ongoing risk management activities. It also specified that a screening assessment of isobutane and butane, in the absence of 1,3-butadiene, would be conducted at a later time.
This screening assessment for short-chain alkanes fulfils the commitment to assess the substances isobutane and butane, in the absence of 1,3-butadiene.